Canada markets open in 4 hours 35 minutes

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.6100+0.0600 (+2.35%)
At close: 04:00PM EDT
2.6000 -0.01 (-0.38%)
After hours: 06:39PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 393.16M
Enterprise Value 492.38M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.84
Price/Book (mrq)12.60
Enterprise Value/Revenue 3.88
Enterprise Value/EBITDA -4.74

Trading Information

Stock Price History

Beta (5Y Monthly) 1.71
52-Week Change 34.51%
S&P500 52-Week Change 322.38%
52 Week High 33.2200
52 Week Low 30.5000
50-Day Moving Average 32.7084
200-Day Moving Average 31.8120

Share Statistics

Avg Vol (3 month) 32.26M
Avg Vol (10 day) 32.55M
Shares Outstanding 5150.64M
Implied Shares Outstanding 6150.64M
Float 8122.08M
% Held by Insiders 10.69%
% Held by Institutions 175.76%
Shares Short (Apr 15, 2024) 425.43M
Short Ratio (Apr 15, 2024) 415.63
Short % of Float (Apr 15, 2024) 419.48%
Short % of Shares Outstanding (Apr 15, 2024) 416.92%
Shares Short (prior month Mar 15, 2024) 425.43M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jan 13, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -87.02%
Operating Margin (ttm)-28.39%

Management Effectiveness

Return on Assets (ttm)-24.56%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)127.04M
Revenue Per Share (ttm)0.92
Quarterly Revenue Growth (yoy)14.00%
Gross Profit (ttm)N/A
EBITDA -90.12M
Net Income Avi to Common (ttm)-110.56M
Diluted EPS (ttm)-0.8000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)80.41M
Total Cash Per Share (mrq)0.54
Total Debt (mrq)179.63M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.37
Book Value Per Share (mrq)-0.23

Cash Flow Statement

Operating Cash Flow (ttm)-58.79M
Levered Free Cash Flow (ttm)-16.84M